Saturday 17 October 2026 Export EIGRQ’s income statement to Excel — free account

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $15.8 million, up 17.0% from fiscal 2022. Revenue growth for three consecutive years, operating cash flow growth for three.

8.50 0.00 0.00%

Follow EIGRQ

Alert me

Market cap: $2.6M
P/E: 0.0×
Fwd P/E: −0.8×
Dividend yield: —
F-score: 4/9
Altman Z: −24.53
Beneish M: −3.24
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Mar '23	Jun '23	Sep '23	Dec '23
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	—	—	4
ROE Full definition →		(146.28%)	(161.95%)	(225.93%)	(367.00%)
ROA Full definition →		(76.75%)	(81.11%)	(86.91%)	(94.31%)
ROIC Full definition →		(14,894.98%)	(2,469.33%)	0.00%	(3,674.55%)
Return on Tangible Assets Full definition →		(131.47%)	(175.56%)	(223.45%)	505.89%
Average Days of Receivables Full definition →		95.13	87.59	32.88	38.92
Free Cash Flow per Share Full definition →		(60.62)	(60.61)	(56.44)	(50.67)
Free Cash Flow Full definition →		(89.11)	(89.41)	(83.30)	(74.78)
Capital Expenditures Full definition →		(0.56)	(0.56)	(0.46)	(0.23)
Other line items
Cash ROIC Full definition →		(59.04%)	(81.60%)	(105.77%)	(143.53%)
Accounts Receivable Turnover Full definition →		4.83	6.51	7.76	9.19
Accounts Payable Turnover Full definition →		0.18	0.19	0.03	0.00
Inventory Turnover Full definition →		0.51	0.70	0.14	0.01
Average Days of Payables Full definition →		2,345.89	1,304.40	6,616.31	32,165.63
Days of Inventory on Hand Full definition →		1,056.03	289.57	1,504.94	23,664.17
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		498.76%	496.53%	472.10%	395.18%
Selling, General and Administrative Expense of Revenue Full definition →		213.06%	195.81%	196.39%	159.79%
Share Based Compensation of Revenue Full definition →		59.03%	47.47%	42.04%	31.75%
Interest Coverage Full definition →		(10.28)	(9.42)	(7.95)	(13.13)
Operating CF/Net income Full definition →		0.91	0.93	0.96	0.99
Depreciation/Fixed assets Full definition →		0.34	(0.50)	(1.14)	(1.33)
Capex/Depreciation Full definition →		(2.05)	1.51	0.59	0.28
Revenue per Share Full definition →		10.16	10.49	9.94	10.69
Operating CF per Share Full definition →		(60.24)	(60.23)	(56.13)	(50.51)
Capex per Share Full definition →		(0.38)	(0.38)	(0.31)	(0.16)
Capex to Sales Full definition →		0.04	0.04	0.03	0.01

Show all line items

Columns are period end dates

Stockrow Weekly